Gå direkte til innhold
 

Call for proposals on vaccination research 2007

Forskerprosjekt Velg
Brukerstyrt innovasjonsprosjekt Velg
Kompetanseprosjekt med brukermedvirkning Velg
Søknadsfrist:
06.06.2007 18:00 CEST

Status:

Gjennomført

Antatt tilgjengelige midler:

A total of approximately 100 mill. NOK is available for this call, of which a maximum of 30 mill. NOK will be available for Norwegian-Indian collaboration as specified in the separate call text. Application deadline is 18:00 hrs June 6th 2007. Earliest possible project start is November 1st 2007.

Føringer og viktige forhold for alle søknadstyper i utlysningen:

The programme for global health and vaccination research (GLOBVAC) consists of two subprogrammes on global health research and on vaccination research, respectively, with separate budgets and separate calls for proposals. This call is for the subprogramme on vaccination research only.

Joint research proposals between Norwegian and Indian partners should follow special guidelines and procedures as specified in separate call text. This call text is for all other proposals on vaccination research.

This call will include researcher projects (link), but also business and industry involvement through user-driven innovation projects (link) and knowledge-building projects with user involvement (link).

 

Thematic guidelines:  

The proposal must be within the field of global vaccination research, which is here defined as  research aiming at providing existing and improved vaccines for marginalized populations, especially children, in low- and middle-income countries. This includes epidemiological studies, the development and evaluation of new or improved vaccines, implementation of vaccination strategies, and studies to measure the costs and outcomes of such strategies. Further, the proposal must be within the overall aims of the GLOBVAC programme as stated above. 

This call will encourage, but is not restricted to, proposals focusing on: 

  • diseases and health problems that account for a large proportion of the global disease burden
  • diseases and health problems that are neglected 
  • thematic areas where Norway is strongly involved in health programmes and research 
  • thematic areas where Norway has the capacity and competence to be in the international forefront 

This includes studies on: 

  • development of diagnostic tools, and identification of the need for vaccination programmes based on epidemiological studies
  • development of new candidate vaccines and identification of optimal formulations and immunization regimens for new and existing vaccines 
  • development of methods to assess vaccine-induced protection (immune correlates), toxicity and side-effects 
  • determination of impact of vaccination, including protective efficacy and effectiveness for relevant outcome parameters and the development of national surveillance systems 
  • increasing the availability and ensuring equitable coverage of existing vaccines 
  • stimulation of technology transfer to low- and middle-income countries, including improved strategies for cost-effective production of vaccines and the development of trial sites. 


General guidelines:

Projects should run over a period of between 2 and 4 years, and must be completed by the end of 2011.

Eligible applicants are public and private Norwegian institutions and companies/organizations. Allocation of funds must contribute to developing high quality projects with participation of Norwegian research environments.

International collaboration, including collaboration with partners in low- and middle-income countries, is encouraged. Proposals must define tasks and funding for each of the international collaborators of the project.

Proposals should include considerations on ethics, capacity building and sustainability.

Normally, projects can have budgets with 1-5 million NOK annually funded from this programme. Projects are encouraged to secure additional funding from other sources (eg. EU-funding, own funding). Further, projects are encouraged where own/additional funding can be shown to lead to sustainable commitments from own institution or other sources beyond the duration of the project.

The scope of the project should be realistic within the time frame and budget limitations of the project. Project activities should be clearly described according to a timeline. Budget information should be clearly written, and detailed in the project proposal when necessary.

Participation of students, PhD and post doctoral fellows should be integral components of a larger project proposal. Proposals consisting of an individual fellowship only, will not be given priority.

Evaluation will be based on scientific merits, relevance for the programme goals and the guidelines of this call, strength of the research group/institution, strategic use of the funding and the probability for success, including expected publication and dissemination of results.


Proposal guidelines and evaluation:

  • The application form and project description (a maximum of 10 pages, font Times New Roman 12 point, footnotes and references included) must be written in English
  • All international cooperation must be documented
  • Proposals will be evaluated by international experts

The GLOBVAC programme board will evaluate and ultimately decide, and at its discretion, which projects will receive funding and the amount for the allocations.

Proposals must be on the format of one of the following application types: Researcher project, User-driven innovation project or Knowledge-building project with user involvement. Proposals must follow the criteria as specified in the guidelines for the relevant application type.